Shirley Kuhlmann

Insider profile

Currently holds a position at Collegium Pharmaceutical Inc

Performance

Overall performance
2.3

Performance over holding periods
2.3
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 23% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Executive Vice President, General Counsel, Secretary Collegium Pharmaceutical Inc March 16, 2018 -

Shirley Kuhlmann's trades of Collegium Pharmaceutical Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-20 2025-03-20 PrS Proposed sale
72,873
386.10
US$3,325,516
72,873 386.10 US$3,325,516
2025-03-06 2025-03-06 PrS Proposed sale
125
130.27
US$3,795,879
125 130.27 US$3,795,879
2025-03-06 2025-03-06 S Sale
22,523 -48.3%
153.01
US$321,764
22,523 -48.3% 153.01 US$321,764
2025-03-06 2025-03-05 S Sale
20,000 -13.0%
28.03
US$560,528
20,000 -13.0% 28.03 US$560,528
2025-03-05 2025-03-05 PrS Proposed sale
20,000
28.03
US$560,528
20,000 28.03 US$560,528
2025-03-06 2025-03-04 S Sale
40,000 -20.6%
28.08
US$1,123,160
40,000 -20.6% 28.08 US$1,123,160
2025-03-04 2025-03-04 PrS Proposed sale
40,000
28.08
US$1,123,160
40,000 28.08 US$1,123,160
2025-01-14 2025-01-10 PlS Planned sale
6,100 -4.9%
33.64
US$205,220
6,100 -4.9% 33.64 US$205,220
2025-01-14 2025-01-10 PlS Planned sale
21,400 -14.6%
32.87
US$703,407
21,400 -14.6% 32.87 US$703,407
2025-01-10 2025-01-10 PrS Proposed sale
27,500
33.04
US$908,628
27,500 33.04 US$908,628
2024-09-06 2024-09-06 PrS Proposed sale
977
37.46
US$36,594
977 37.46 US$36,594
2024-09-06 2024-09-06 S Sale
977 -0.8%
37.46
US$36,594
977 -0.8% 37.46 US$36,594
2024-09-06 2024-09-05 S Sale
2,400 -2.0%
39.14
US$93,941
2,400 -2.0% 39.14 US$93,941
2024-09-06 2024-09-05 S Sale
16,848 -12.1%
38.18
US$643,257
16,848 -12.1% 38.18 US$643,257
2024-09-05 2024-09-05 PrS Proposed sale
19,248
38.30
US$737,197
19,248 38.30 US$737,197
2024-06-05 2024-06-03 PlS Planned sale
700 -0.5%
33.22
US$23,254
700 -0.5% 33.22 US$23,254
2024-06-05 2024-06-03 PlS Planned sale
24,300 -14.8%
32.55
US$790,926
24,300 -14.8% 32.55 US$790,926
2024-06-03 2024-06-03 PrS Proposed sale
25,000
32.83
US$820,750
25,000 32.83 US$820,750
2023-11-29 2023-11-27 PlS Planned sale
25,600 -17.6%
25.78
US$660,014
25,600 -17.6% 25.78 US$660,014
2023-11-27 2023-11-27 PrS Proposed sale
25,600
25.78
US$660,013
25,600 25.78 US$660,013
2023-06-28 2023-06-26 PlS Planned sale
1,363 -1.1%
22.53
US$30,715
1,363 -1.1% 22.53 US$30,715
2023-06-28 2023-06-26 PlS Planned sale
16,621 -12.1%
21.65
US$359,918
16,621 -12.1% 21.65 US$359,918
2023-06-26 2023-06-26 PrS Proposed sale
17,984
22.59
US$406,259
17,984 22.59 US$406,259
2023-02-14 2023-02-13 PlS Planned sale
21,811 -13.7%
26.88
US$586,280
21,811 -13.7% 26.88 US$586,280
2022-09-16 2022-09-15 PlS Planned sale
38,589 -26.1%
18.07
US$697,303
38,589 -26.1% 18.07 US$697,303
2022-08-15 2022-08-11 PlS Planned sale
300 -0.2%
20.01
US$6,003
300 -0.2% 20.01 US$6,003
2021-05-12 2021-05-10 PlS Planned sale
7,000 -7.2%
22.77
US$159,390
7,000 -7.2% 22.77 US$159,390
2021-01-21 2021-01-20 PlS Planned sale
6,081 -5.5%
24.45
US$148,680
6,081 -5.5% 24.45 US$148,680
2020-10-16 2020-10-15 PlS Planned sale
7,060 -10.9%
20.82
US$146,989
7,060 -10.9% 20.82 US$146,989